FDA's commitment to transparency

被引：0

作者：

Guharoy, Roy ^{[1
,2
]}

Krenzelok, Edward ^{[3
]}

机构：

[1] Baptist Hlth, Dept Pharm, Montgomery, AL 36117 USA

[2] Univ Massachusetts, Sch Med, Montgomery, AL 36117 USA

[3] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2021年 / 78卷 / 17期

关键词：

D O I：

10.1093/ajhp/zxab053

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1550 / 1551

页数：2

共 50 条

[41] Central bank reputation, cheap talk and transparency as substitutes for commitment: Experimental evidence
Duffy, John
Heinemann, Frank
JOURNAL OF MONETARY ECONOMICS, 2021, 117 : 887 - 903
[42] The value of firms' voluntary commitment to improve transparency: The case of special segments on Euronext
Kim, Abby
JOURNAL OF CORPORATE FINANCE, 2014, 25 : 342 - 359
[43] From optimism to disillusion about commitment to transparency in the medico-industrial complex
Chalmers, Iain
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (07) : 337 - 341
[44] Cheap talk or incredible commitment? (Mis)calculating transparency and anti-corruption
Schnell, Sabina
GOVERNANCE-AN INTERNATIONAL JOURNAL OF POLICY ADMINISTRATION AND INSTITUTIONS, 2018, 31 (03): : 415 - 430
[45] THE WRITER'S COMMITMENT
Riechmann, Jorge
CELEHIS-REVISTA DEL CENTRO DE LETRAS HISPANOAMERICANAS, 2008, (19): : 189 - 189
[46] Industry's commitment
Webber, FL
CHEMICAL & ENGINEERING NEWS, 1998, 76 (45) : 5 - 5
[47] Commitment to the supervisor, organizational commitment, and supervisor's organizational commitment: A balance perspective
Jiang, Ding Ju
Wang, Yu-Hsuan
Wu, Hsu-Chu
INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (3-4) : 636 - 636
[48] Food and drug administration (FDA)'s impact on laboratory performance: FDA's perspective
Gutman, S
CLINICAL CHEMISTRY, 1996, 42 (05) : 786 - 789
[49] China's new FDA
不详
ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (16) : A873 - A873
[50] Preserve the FDA's authority
Guharoy, R
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (21) : 2636 - &

← 1 2 3 4 5 →